(Q45306316)

11 December 2017

title

Therapeutic effects of paclitaxel-containing ultrasound contrast agents (English)

1 reference

11 December 2017

1 reference

7

1 reference

11 December 2017

5

Susanne M Stieger

1 reference

11 December 2017

author name string

Michaelann Shortencarier Tartis

1

1 reference

11 December 2017

Jennifer McCallan

2

1 reference

11 December 2017

Aaron F H Lum

3

1 reference

11 December 2017

Rachel LaBell

4

1 reference

11 December 2017

Terry O Matsunaga

6

1 reference

11 December 2017

publication date

1 November 2006

1 reference

Ultrasound in Medicine and Biology

11 December 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

11 December 2017

volume

32

1 reference

11 December 2017

issue

11

1 reference

11 December 2017

page(s)

1771-1780

1 reference

Dynamics of therapeutic ultrasound contrast agents

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Targeting integrins: insights into structure and activity of cyclic RGD pentapeptide mimics containing azabicycloalkane amino acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Requirement of vascular integrin alpha v beta 3 for angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Synthesis and solution conformation of cyclo[RGDRGD]: a cyclic peptide with selectivity for the alpha V beta 3 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Threshold of fragmentation for ultrasonic contrast agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

A preliminary evaluation of the effects of primary and secondary radiation forces on acoustic contrast agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Acoustic radiation force in vivo: a mechanism to assist targeting of microbubbles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

The magnitude of radiation force on ultrasound contrast agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Angiogenesis in cancer, vascular, rheumatoid and other disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Role of angiogenesis in tumor growth and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Vascular-targeted nanoparticles for molecular imaging and therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Intravascular ultrasound molecular imaging of atheroma components in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Tumor regression by targeted gene delivery to the neovasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Direct Video-Microscopic Observation of the Dynamic Effects of Medical Ultrasound on Ultrasound Contrast Microspheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Targeted ultrasonic contrast agents for molecular imaging and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Acoustic effects on gas bubbles in the flows of viscous fluids and whole blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Integrin expression in human melanoma cell lines: heterogeneity of vitronectin receptor composition and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Dynamics and fragmentation of thick-shelled microbubbles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Consequences of angiogenesis for tumor progression, metastasis and cancer therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Activation status and function of the VLA-4 (alpha4beta1) integrin expressed on human melanoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Integrins and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Local drug and gene delivery through microbubbles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Therapeutic applications of lipid-coated microbubbles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Integrin alphavbeta3 as a target for blocking HIV-1 Tat-induced endothelial cell activation in vitro and angiogenesis in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Paclitaxel-induced cell death: where the cell cycle and apoptosis come together

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

Radiation-force assisted targeting facilitates ultrasonic molecular imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

A method for radiation-force localized drug delivery using gas-filled lipospheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2006.03.017

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.ULTRASMEDBIO.2006.03.017

1 reference

11 December 2017

1 reference